Amneal Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AMRX and other ETFs, options, and stocks.

About AMRX

Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog. 

CEO
Chintu Patel
CEOChintu Patel
Employees
8,500
Employees8,500
Headquarters
Bridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded
2002
Founded2002
Employees
8,500
Employees8,500

AMRX Key Statistics

Market cap
5.50B
Market cap5.50B
Price-Earnings ratio
35.50
Price-Earnings ratio35.50
Dividend yield
Dividend yield
Average volume
1.72M
Average volume1.72M
High today
$17.30
High today$17.30
Low today
$16.98
Low today$16.98
Open price
$17.11
Open price$17.11
Volume
1.50M
Volume1.50M
52 Week high
$19.26
52 Week high$19.26
52 Week low
$9.49
52 Week low$9.49

Stock Snapshot

Amneal Pharmaceuticals(AMRX) stock is priced at $17.22, giving the company a market capitalization of 5.5B. It carries a P/E multiple of 35.50.

On 2026-09-15, Amneal Pharmaceuticals(AMRX) stock moved within a range of $16.98 to $17.30. With shares now at $17.22, the stock is trading +1.4% above its intraday low and -0.5% below the session's peak.

Trading volume for Amneal Pharmaceuticals(AMRX) stock has reached 1.5M, versus its average volume of 1.72M.

The stock's 52-week range extends from a low of $9.49 to a high of $19.26.

The stock's 52-week range extends from a low of $9.49 to a high of $19.26.

AMRX News

Nasdaq 5d
Leerink Partners Initiates Coverage of Amneal Pharmaceuticals at Outperform

Fintel reports that on September 9, 2026, Leerink Partners initiated coverage of Amneal Pharmaceuticals (NASDAQGS:AMRX) with a Outperform recommendation. This i...

Leerink Partners Initiates Coverage of Amneal Pharmaceuticals at Outperform
TipRanks 6d
Amneal Pharmaceuticals initiated with an Outperform at Leerink

Leerink initiated coverage of Amneal Pharmaceuticals (AMRX) with an Outperform rating and $23 price target Published first on TheFly – the ultimate source for...

Analyst ratings

100%

of 7 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own AMRX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.